Literature DB >> 27355540

Implementation of RTS,S/AS01 Malaria Vaccine--The Need for Further Evidence.

John Clemens1, Vasee Moorthy1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27355540     DOI： 10.1056/NEJMe1606007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

Review 1.  Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.

Authors:  Amy Grenham; Tonya Villafana
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

2.  Active Safety Surveillance in Africa: Pragmatism and Agility.

Authors:  Alexander N O Dodoo
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

3.  A Plasmodium Parasite with Complete Late Liver Stage Arrest Protects against Preerythrocytic and Erythrocytic Stage Infection in Mice.

Authors:  Ashley M Vaughan; Brandon K Sack; Dorender Dankwa; Nana Minkah; Thao Nguyen; Hayley Cardamone; Stefan H I Kappe
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

4.  Chimeric Plasmodium falciparum parasites expressing Plasmodium vivax circumsporozoite protein fail to produce salivary gland sporozoites.

Authors:  Catherin Marin-Mogollon; Fiona J A van Pul; Shinya Miyazaki; Takashi Imai; Jai Ramesar; Ahmed M Salman; Beatrice M F Winkel; Ahmad Syibli Othman; Hans Kroeze; Severine Chevalley-Maurel; Arturo Reyes-Sandoval; Meta Roestenberg; Blandine Franke-Fayard; Chris J Janse; Shahid M Khan
Journal:  Malar J       Date:  2018-08-09       Impact factor: 2.979

5.  Microtubule number and length determine cellular shape and function in Plasmodium.

Authors:  Benjamin Spreng; Hannah Fleckenstein; Patrick Kübler; Claudia Di Biagio; Madlen Benz; Pintu Patra; Ulrich S Schwarz; Marek Cyrklaff; Friedrich Frischknecht
Journal:  EMBO J       Date:  2019-05-24       Impact factor: 11.598

Review 6.  Reassessing therapeutic antibodies for neglected and tropical diseases.

Authors:  Rob Hooft van Huijsduijnen; Somei Kojima; Dee Carter; Hisafumi Okabe; Akihide Sato; Wataru Akahata; Timothy N C Wells; Kei Katsuno
Journal:  PLoS Negl Trop Dis       Date:  2020-01-30

7.  Generation of a Genetically Modified Chimeric Plasmodium falciparum Parasite Expressing Plasmodium vivax Circumsporozoite Protein for Malaria Vaccine Development.

Authors:  Yukiko Miyazaki; Catherin Marin-Mogollon; Takashi Imai; António M Mendes; Rianne van der Laak; Angelika Sturm; Fiona J A Geurten; Shinya Miyazaki; Severine Chevalley-Maurel; Jai Ramesar; Surendra K Kolli; Hans Kroeze; Roos van Schuijlenburg; Ahmed M Salman; Brandon K Wilder; Arturo Reyes-Sandoval; Koen J Dechering; Miguel Prudêncio; Chris J Janse; Shahid M Khan; Blandine Franke-Fayard
Journal:  Front Cell Infect Microbiol       Date:  2020-12-17       Impact factor: 5.293

8.  Vaccine Containing the Three Allelic Variants of the Plasmodium vivax Circumsporozoite Antigen Induces Protection in Mice after Challenge with a Transgenic Rodent Malaria Parasite.

Authors:  Alba Marina Gimenez; Luciana Chagas Lima; Katia Sanches Françoso; Priscila M A Denapoli; Raquel Panatieri; Daniel Y Bargieri; Jean-Michel Thiberge; Chiara Andolina; Francois Nosten; Laurent Renia; Ruth S Nussenzweig; Victor Nussenzweig; Rogerio Amino; Mauricio M Rodrigues; Irene S Soares
Journal:  Front Immunol       Date:  2017-10-11       Impact factor: 7.561

9.  Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus.

Authors:  Akane Urakami; Atsuko Sakurai; Momoko Ishikawa; Moh Lan Yap; Yevel Flores-Garcia; Yasunari Haseda; Taiki Aoshi; Fidel P Zavala; Michael G Rossmann; Sachiko Kuno; Ryuji Ueno; Wataru Akahata
Journal:  Clin Vaccine Immunol       Date:  2017-07-05

10.  Increased Plasmodium falciparum Parasitemia in Non-splenectomized Saimiri sciureus Monkeys Treated with Clodronate Liposomes.

Authors:  Janaiara A Cunha; Leonardo J M Carvalho; Cesare Bianco-Junior; Márcia C R Andrade; Lilian R Pratt-Riccio; Evelyn K P Riccio; Marcelo Pelajo-Machado; Igor J da Silva; Pierre Druilhe; Cláudio Tadeu Daniel-Ribeiro
Journal:  Front Cell Infect Microbiol       Date:  2017-09-21       Impact factor: 5.293
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.